Mode
Text Size
Log in / Sign up

Moxibustion Combination Therapies Improve Nerve Conduction and Clinical Scores in Diabetic NeuropathyMoxibustion combinations may improve nerve function in diabetic neuropathy

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Moxibustion combined with external herbal medicine or acupuncture may improve nerve conduction and clinical scores in DPN.

This network meta-analysis evaluated various moxibustion combinations compared to conventional treatment for patients with diabetic peripheral neuropathy. The study analyzed several modalities, including moxibustion combined with acupuncture, massage, internal herbal medicine, and external herbal medicine.

Results indicated that moxibustion combined with external herbal medicine (EHM) significantly improved common peroneal motor and sensory nerve conduction velocities compared to standard care. Additionally, patients receiving the MOXI+EHM combination showed a statistically significant reduction in Toronto Clinical Scoring System scores, indicating improved clinical outcomes.

Moxibustion combined with acupuncture also demonstrated superior results in median sensory nerve conduction velocity and higher markedly effective rates compared to conventional treatments. While the evidence for some specific nerve conduction metrics varied in certainty, the overall data suggests these combinations may provide meaningful benefits.

Clinicians may consider moxibustion-based combination therapies as a viable adjunct to conventional management for diabetic peripheral neuropathy. However, because the current findings are based on a network meta-analysis, the results require confirmation through more rigorous, large-scale clinical trials to establish definitive protocols.

How this fits prior evidence

This finding addresses a gap in non-pharmacological management for diabetic peripheral neuropathy. While previous evidence highlights the role of intravenous alpha-lipoic acid for symptom relief and the impact of nerve decompressive surgery on pain scores, this meta-analysis explores moxibustion-based therapies as a potential adjunct to conventional management. The study specifically provides data on nerve conduction velocities and clinical scoring systems, which are not addressed in the previously covered evidence regarding alpha-lipoic acid or surgical interventions.

Living with diabetic peripheral neuropathy can be incredibly frustrating. It often causes nerve damage that leads to pain or numbness in the limbs. Researchers looked at how combining moxibustion—a traditional therapy involving heat—with other treatments compares to standard care for these patients.

In a review of data from over 3,700 patients, researchers found that combining moxibustion with external herbal medicine outperformed standard treatment in several areas. Specifically, it showed improvements in nerve conduction speeds and better scores on the Toronto Clinical Scoring System, which measures how well a patient functions. Adding acupuncture to moxibustion also showed some improvement in nerve conduction compared to standard care.

While these results are promising, the evidence is not yet certain. Some findings were based on lower-quality data, and the study notes that these results need to be confirmed by more rigorous trials. For now, these moxibustion-based combinations might offer a helpful extra step in managing the symptoms of diabetic nerve damage.

What this means for you:
Moxibustion combined with herbal medicine or acupuncture may improve nerve function in diabetic neuropathy.

Common questions

What is moxibustion and how does it help?

Moxibustion is a traditional therapy that involves applying heat to specific points. When combined with external herbal medicine or acupuncture, it was found to improve nerve conduction speeds and clinical scores for people with diabetic peripheral neuropathy compared to standard treatment.

Is moxibustion combined with herbal medicine effective?

Yes, the data showed that combining moxibustion with external herbal medicine improved nerve conduction speeds and resulted in a lower Toronto Clinical Scoring System score compared to standard treatment. It also showed a higher rate of being markedly effective.

How certain are these results for diabetic neuropathy?

The evidence is currently of moderate certainty for some improvements, but some findings are based on lower-quality data. Because of this, the results need to be confirmed in more rigorous trials before they can be fully confirmed as a standard practice.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
ObjectiveMoxibustion, an external treatment used in traditional Chinese medicine, is increasingly applied to diabetic peripheral neuropathy (DPN). We compared the effectiveness of the principal moxibustion-containing treatment combinations for this condition. We searched for randomised controlled trials (RCTs) available by 14 April 2026. Sources were PubMed, EMBASE, the Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Medical Database and VIP Database. The resulting network meta-analysis (NMA) covered moxibustion (MOXI) and combinations with acupuncture therapy (ACU), massage therapy (MT), internal herbal medicine (IHM), external herbal medicine (EHM) or conventional treatment (CT). Outcomes included common peroneal and median motor nerve conduction velocity (MNCV), sensory nerve conduction velocity (SNCV), Toronto Clinical Scoring System (TCSS) score and markedly effective rate. Random-effects models in Stata MP 17.0 generated mean differences (MDs) and risk ratios (RRs). Evidence certainty was graded with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework.ResultsForty studies involving 3,718 participants were included. Moderate-certainty evidence favoured MOXI+EHM over CT for common peroneal MNCV (MD = 6.14 m/s, 95% CI 3.82 to 8.46). Evidence also favoured MOXI+EHM for median MNCV (MD = 6.35 m/s, 95% CI 2.35 to 10.36). The corresponding estimate for common peroneal SNCV was MD = 8.44 m/s (95% CI 4.80 to 12.08). For median SNCV, MOXI+ACU outperformed CT (MD = 6.61 m/s, 95% CI 1.29 to 11.92). MOXI+EHM showed a similar effect (MD = 4.32 m/s, 95% CI 1.01 to 7.63). Certainty for this outcome ranged from moderate to very low. Moderate-certainty evidence also showed that MOXI+EHM reduced TCSS scores (MD=-2.55 points, 95% CI -3.81 to -1.30). MOXI+EHM (RR = 1.74, 95% CI 1.27 to 2.40) and MOXI+ACU (RR = 1.59, 95% CI 1.05 to 2.41) increased the markedly effective rate versus CT.ConclusionModerate-certainty evidence suggests that MOXI+EHM may improve nerve conduction, clinical symptoms and signs, and the markedly effective rate in patients with DPN. Moxibustion-based combination therapy may therefore offer a useful adjunct to conservative DPN management, although the findings require confirmation in rigorous trials.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420261444059, identifier CRD420261444059.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.